Jan 18, 2019 03:09 PM IST
Net Sales are expected to decrease by 5 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 534 crore, according to Sharekhan.
- Jan 11, 2019 06:07 PM IST
Net Sales are expected to decrease by 4.9 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 534.7 crore, according to ICICI Direct.
- Oct 17, 2018 11:28 AM IST
Net Sales are expected to increase by 20 percent Y-o-Y (down 4.9 percent Q-o-Q) to Rs. 512 crore, according to Sharekhan.
- Oct 12, 2018 05:35 PM IST
Net Sales are expected to increase by 31.3 percent Y-o-Y (up 4 percent Q-o-Q) to Rs. 560.1 crore, according to ICICI Direct.
- Apr 16, 2018 06:25 PM IST
Net Sales are expected to increase by 29 percent Y-o-Y (up 30.5 percent Q-o-Q) to Rs. 745.1 crore, according to Edelweiss.
- Apr 12, 2018 05:53 PM IST
Analysts predict the last quarter of FY18 to be mixed bag with revenues expected to remain almost flat to a growth of lower single digit on year-on-year basis. The net profit is predicted to decline by around 9-10 percent.
- Jan 18, 2018 08:36 AM IST
As Indian drug makers brace up to report their third quarter earnings in the days ahead, analysts predict Q3 FY18 to be mixed bag with revenues expected to remain flat on year-on-year basis, though on sequential basis things may look much better.
- Apr 17, 2017 01:51 PM IST
Net Sales are expected to decrease by 18.5 percent Q-o-Q (up 36 percent Y-o-Y) to Rs 553.4 crore, according to ICICI Securities. Natco Pharma to report net profit at 156.1 crore down 26.8% quarter-on-quarter.
- Jan 16, 2017 12:46 PM IST
Net Sales are expected to decrease by 1.8 percent Q-o-Q (up 66.4 percent Y-o-Y) to Rs 459.3 crore, according to ICICI Securities.
- Aug 10, 2016 11:36 AM IST
Jubilant Life Sciences working on reducing its debt through internal accruals against taking fresh loan will serve well for its future growth says Surajit Pal, Prabhudas Lilladher.
- Jul 16, 2016 01:08 PM IST
Sales are expected to decrease by 20.6 percent Q-o-Q (up 44.4 percent Y-o-Y) to Rs 323.0 crore, according to Religare Research.
- Jul 14, 2016 06:19 PM IST
Net Sales are expected to decrease by 29 percent Q-o-Q (up 29.1 percent Y-o-Y) to Rs 288.8 crore, according to Edelweiss
- Jan 03, 2014 05:34 PM IST
Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), revenue growth is expected to be 19 percent Y-o-Y.
- Nov 18, 2013 01:16 PM IST
Bhaskar Narayana, Finance Director & CFO, Natco Pharma is confident of maintaining the current growth rate in terms of margins going forward.
- Feb 14, 2013 02:44 PM IST
Hyderabad-based Natco Pharma Limited, on December 21, received the approval from Food & Drug Administration (FDA) for marketing the prescription version of Lanzoprazole, CFO of the company Bhaskar Narayana told CNBC-TV18 in an interview.